- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Volitionrx Ltd (VNRX)
Assess today's live Volitionrx Ltd (VNRX) share price, performance and insights using our live NYSE: VNRX stock exchange data.
Analyse the historical data and Volitionrx Ltd share price performance charts on this page. Our technical summary section provides analysis on Volitionrx Ltd share price buy/sell indicators using real-time data (or discuss the Volitionrx Ltd (VNRX) stock price today with other investors in the Volitionrx Ltd NYSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NYSE VNRX share price (ISIN: US9286611077) to enhance your trading decisions with our free investment tools and resources.
What Is the Volitionrx Ltd Share Price Today?
The Volitionrx Ltd share price today is 0.285.
What Is the Stock Symbol for Volitionrx Ltd
The stock symbol (or 'ticker') for Volitionrx Ltd is "VNRX."
What Stock Exchange Does Volitionrx Ltd Trade On?
Volitionrx Ltd is listed and trades on the NYSE stock exchange.
Is Volitionrx Ltd a Good Stock to Buy?
Determining whether Volitionrx Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Volitionrx Ltd share price performance charts on this page. Our technical summary section provides analysis on Volitionrx Ltd share price buy/sell indicators using real-time data (or discuss the Volitionrx Ltd (VNRX) stock price today with other investors in the Volitionrx Ltd NYSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NYSE VNRX share price (ISIN: US9286611077) to enhance your trading decisions with our free investment tools and resources.
What Is the Volitionrx Ltd Share Price Today?
The Volitionrx Ltd share price today is 0.285.
What Is the Stock Symbol for Volitionrx Ltd
The stock symbol (or 'ticker') for Volitionrx Ltd is "VNRX."
What Stock Exchange Does Volitionrx Ltd Trade On?
Volitionrx Ltd is listed and trades on the NYSE stock exchange.
Is Volitionrx Ltd a Good Stock to Buy?
Determining whether Volitionrx Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.266
0.315
52 wk Range
0.220
0.940
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.2660.315
52 wk Range
0.2200.940
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
VNRX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PricePrice Target
2.200
Upside
+671.93%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
2 analysts have revised their earnings downwards for the upcoming period
- Form 8K Volitionrx Ltd For: 8 January
- Investing.com
- Form 8K Volitionrx Ltd For: 8 January
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Volitionrx Ltd Company Profile
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes; Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient’s cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is based in Henderson, Nevada.
Volitionrx Ltd Earnings Call Summary for Q3/2025
- VolitionRx reported Q3 2025 revenue of $0.6M (up 32% YoY), but missed EPS expectations with -$0.05 vs -$0.0375 forecast, representing a 33.33% negative surprise.
- The company reduced operating expenses by 10% and decreased net cash used in operations by 33% to $3.6M, demonstrating improved operational efficiency.
- Stock remained stable post-earnings with a slight 0.14% increase during market hours and 2.25% rise in premarket trading, despite revenue falling 68.32% short of forecasts.
- Management secured $6.1M from a public offering post-quarter and projects EPS of -$0.04 for upcoming quarters, while anticipating multiple partnerships in 2026.
- CEO Cameron Reynolds highlighted NETs as 'the next big things' with the company focusing on commercializing its Nu.Q platform across oncology, preparing for first clinical use in Europe.
Last Updated: 14/11/2025, 14:50
Read Full TranscriptCompare VNRX to Peers and Sector
Metrics to compare | VNRX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVNRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.5x | −0.3x | −0.6x | |
PEG Ratio | −0.04 | 0.00 | 0.00 | |
Price/Book | −1.0x | 2.0x | 2.6x | |
Price / LTM Sales | 23.8x | 11.0x | 3.4x | |
Upside (Analyst Target) | - | 49.5% | 44.9% | |
Fair Value Upside | Unlock | −8.5% | 6.7% | Unlock |
Analyst Ratings
4 Buy
2 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 2.200
(+671.93% Upside)
Earnings
Latest Release
Nov 13, 2025
EPS / Forecast
-0.05 / -0.0375
Revenue / Forecast
627.28K / 1.98M
People Also Watch
FAQ
What Is the Volitionrx Ltd (VNRX) Share Price Today?
The live Volitionrx Ltd share price today is 0.285
What Stock Exchange Does Volitionrx Ltd (VNRX) Trade On?
Volitionrx Ltd is listed and trades on the New York Stock Exchange.
What Is the Ticker (Stock Symbol) for Volitionrx Ltd?
The stock symbol (also called a 'ticker') for Volitionrx Ltd is "VNRX."
What Is the Current Volitionrx Ltd Market Cap?
As of today, Volitionrx Ltd market capitalisation is 35.24M.
What Is Volitionrx Ltd's (VNRX) Earnings Per Share (TTM)?
The Volitionrx Ltd EPS is currently -0.23 (Trailing Twelve Months).
When Is the Next Volitionrx Ltd Earnings Date?
Volitionrx Ltd's next earnings report will be released on 30 Mar 2026.
Is VNRX a Buy or Sell From a Technical Analyst Perspective?
Based on today's Volitionrx Ltd moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Many Times Has Volitionrx Ltd Stock Split?
Volitionrx Ltd has split 0 times. (See the VNRX stock split history page for full effective split date and price information.)
How Many Employees Does Volitionrx Ltd Have?
Volitionrx Ltd has 75 employees.
What is the current trading status of Volitionrx Ltd (VNRX)?
As of 31 Jan 2026, Volitionrx Ltd (VNRX) is trading at a price of 0.285, with a previous close of 0.251. The stock has fluctuated within a day range of 0.266 to 0.315, while its 52-week range spans from 0.220 to 0.940.
What Is Volitionrx Ltd (VNRX) Price Target According to Analysts?
The average 12-month price target for Volitionrx Ltd is USD2.200, with a high estimate of USD3 and a low estimate of USD1. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +671.93% Upside potential.
What Is the VNRX Premarket Price?
VNRX's last pre-market stock price is 0.282. The pre-market share volume is 621,880.000, and the stock has decreased by 0.031, or 12.350%.
What Is the VNRX After Hours Price?
VNRX's last after hours stock price is 0.297, the stock has decreased by 0.012, or 4.350%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.